Get StockBox https://www.a1trading.com/stockbox/
5 extracted signals · 5 resolved · 0 still active
TraderNick - StocksIndependent analyst profile- Source published
- 22 Jul 2025, 17:38 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC
AI-generated source summary
The analyst reviews a range of stocks, beginning with Alphabet (GOOGL), noting the stock is undervalued, estimating a pull back to 180 for a good entry point, implying a buy-the-dip strategy. The A1 extension zones show GOOGL at the upper limits, indicating an overbought level in the short term.Moving to Accenture (ACN), the analyst points out a -28% drop and the stock sitting at a longer-term support level of 275 dollars, viewing this as a potential entry point, implying a long position with a target of 310. The SPDR Select Sector Fund (XLV) the healthcare ETF, analysts expect an uptrend to around 140 but due to the broad market conditions its better a more safe estimate, he expects to touch 135. UnitedHealth Group (UNH) he sees a large dip but finds its very atractive its around 350 dollars. The analysis then uses the A1 Stockbox tool to view and analyze PE ratios.The analysis finishes with Abbott Laboratories (ABT) indicating using his indicator (AI Extension Zones indicator), he could do a cash secured put out of the money, showing rising volatility which could bring the price to 115.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
5 eligible signals linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
TraderNick - Stocks
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.